Actively Recruiting

Phase Not Applicable
Age: 14Years - 18Years
All Genders
ID06709755

A Hybrid Effectiveness-implementation Trial of an Intervention to Reduce Diabetes-specific Emotional Distress in Teenagers

Led by Jill Weissberg-Benchell, Ph.D. · Updated on 2026-05-29

360

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

J

Jill Weissberg-Benchell, Ph.D.

Lead Sponsor

A

American Diabetes Association

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to evaluate the effectiveness and implementation of Supporting Teen Problem Solving (STePS), an intervention designed to reduce diabetes-specific emotional distress in teenagers with Type 1 Diabetes Mellitus. The study includes 360 teens aged 14 to 18 from diverse backgrounds across six clinical sites. It compares STePS delivered in-person or via telehealth against an educational control group, focusing on improving emotional distress and preventing worsening blood sugar control over time. Participants are randomly assigned to one of three groups: STePS in-person, STePS via telehealth, or diabetes education via telehealth. Each group participates in a 4.5-month program consisting of nine sessions held twice monthly. STePS is a group-based behavioral intervention teaching emotion regulation and problem-solving skills to help teens manage diabetes-related distress. The study also examines how these delivery methods affect the uptake and sustainability of the intervention in real-world diabetes clinics. Throughout the study, participants complete surveys at the start, immediately after the intervention, and at 6 and 12 months post-intervention to measure diabetes distress and blood sugar control (Time in Range). Qualitative data from focus groups will explore participant and provider experiences. Researchers will assess recruitment, adherence, acceptability, costs, and program fidelity. The total participation spans about 16.5 months, including follow-up assessments to evaluate both clinical and practical outcomes of the intervention.

CONDITIONS

Brief Title

A Hybrid Effectiveness-implementation Trial to Reduce Diabetes Distress in Teenagers

Who Can Participate

Age: 14Years - 18Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with Type 1 Diabetes Mellitus for at least 1 year
  • Using daily basal and bolus insulin
  • Fluent in English
  • Able to provide caregiver consent and teen assent
  • Able to access telehealth via a digital device
  • Focus on recruiting diverse teens including racial and ethnic minorities, low socioeconomic status, public aid recipients, or rural residents
Not Eligible

You will not qualify if you...

  • Presence of cognitive or developmental disorders
  • Being a ward of the state

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person or virtual) for screening and enrollment

Outpatient Treatment

Duration - Approximately 4.5 months

Participants receive a 9-session group-based intervention, either in-person or via telehealth, aimed at reducing diabetes-specific emotional distress and building diabetes resilience, or receive diabetes education delivered virtually.

9 group sessions over about 4.5 months

Follow-up

Duration - Up to 12 months post intervention

Participants are assessed for diabetes distress and glycemic control at the end of the intervention and at 6 and 12 months post intervention to evaluate the lasting effects of the intervention.

3 follow-up assessments: at end of intervention, 6 months, and 12 months post intervention

Trial Site Locations

Total: 1 location

1

Ann and Robert H Lurie Childrens Hospital of Chicago

Chicago, Illinois, United States, 60611

Actively Recruiting

Loading map...

Research Team

J

Jill Weissberg-Benchell Professor, Ph.D.

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

3

Similar Trials

Fully Closed-Loop Glucose Control in Adults With Type 1 Diab...

Type 1 Diabetes

Actively Recruiting

4 locations

POLARIS: A Phase 1, Single Dose, Open-label Study of GNTI-12...

Type 1 Diabetes (T1D)

Actively Recruiting

10 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Supporting Teen Problem-Solving (STEPS) 3 year outcomes: Preventing diabetes-specific emotional distress and depressive symptoms in adolescents with type 1 diabetes.

Jill Weissberg-Benchell, Jenna B Shapiro, Fred B Bryant...

https://pubmed.ncbi.nlm.nih.gov/33136423